Showing 1 to 2 of 2 results


Trump Administration Rejects Medicare Coverage for Obesity Medications
The Trump administration decided against covering costly obesity medications under Medicare Part D, rejecting a Biden-era proposal that would have cost taxpayers up to $35 billion over 10 years, despite polls showing public support and evidence suggesting that treating obesity can reduce long-term h...
Trump Administration Rejects Medicare Coverage for Obesity Medications
The Trump administration decided against covering costly obesity medications under Medicare Part D, rejecting a Biden-era proposal that would have cost taxpayers up to $35 billion over 10 years, despite polls showing public support and evidence suggesting that treating obesity can reduce long-term h...
Progress
48% Bias Score

Trump Administration Blocks Expansion of Anti-Obesity Drug Coverage
The Trump administration blocked a Biden plan to expand Medicare and Medicaid coverage of expensive anti-obesity drugs, citing fiscal concerns and the need for further review, impacting millions of Americans and leaving access to these medications limited.

Trump Administration Blocks Expansion of Anti-Obesity Drug Coverage
The Trump administration blocked a Biden plan to expand Medicare and Medicaid coverage of expensive anti-obesity drugs, citing fiscal concerns and the need for further review, impacting millions of Americans and leaving access to these medications limited.
Progress
52% Bias Score
Showing 1 to 2 of 2 results